EDITORIAL
Published on 27 Sep 2022
Editorial: C. elegans as an emerging model of pharmacological innovation
doi 10.3389/fphar.2022.1029752
- 1,579 views
- 5 citations
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- C. elegans as an Emerging Model of Pharmacological Innovation
C. elegans as an Emerging Model of Pharmacological Innovation
6,571
Total downloads
24k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 14 Sep 2022
Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals
doi 10.3389/fphar.2022.938650
- 5,222 views
- 7 citations
ORIGINAL RESEARCH
Published on 22 Aug 2022
Flavonol glycoside complanatoside A requires FOXO/DAF-16, NRF2/SKN-1, and HSF-1 to improve stress resistances and extend the life span of Caenorhabditis elegans
doi 10.3389/fphar.2022.931886
- 3,730 views
- 10 citations
ORIGINAL RESEARCH
Published on 16 Jun 2022
Santalol Isomers Inhibit Transthyretin Amyloidogenesis and Associated Pathologies in Caenorhabditis elegans
doi 10.3389/fphar.2022.924862
- 2,453 views
- 2 citations
ORIGINAL RESEARCH
Published on 24 May 2022
1-Mesityl-3-(3-Sulfonatopropyl) Imidazolium Protects Against Oxidative Stress and Delays Proteotoxicity in C. elegans
doi 10.3389/fphar.2022.908696
- 1,859 views
- 5 citations
REVIEW
Published on 28 Apr 2022
Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions
doi 10.3389/fphar.2022.875349
- 4,082 views
- 14 citations
Published in
Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
Impact
- 24kTopic views
- 16kArticle views
- 6,571Article downloads